Wen-Chien Chou

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Venues

Blood cancer journal

Blood advances

British journal of haematology

Oncogene

National Taiwan University Hospital

Johns Hopkins University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Taiwan University Hospital

Taiwan

Director :: Department of Laboratory Medicine

National Taiwan University

Taiwan

Professor :: Department of Lab Medicine, College of Medicine

National Taiwan University Hospital

Taiwan

Attending physician :: Department of Laboratory Medicine and Internal Medicine

Johns Hopkins University

United States

Government-supported graduate study

National Taiwan University Hospital Yun-Lin Branch

Taiwan

Attending physician :: Department of Internal Medicine

Johns Hopkins University

United States

Ph.D. training :: Human Genetics Program

Johns Hopkins University

United States

Post-doctoral fellow :: Human Genetics

National Taiwan University Hospital

Taiwan

Training in medical oncology

National Taiwan University Hospital

Taiwan

Training in hematology

National Taiwan University Hospital

Taiwan

Training in general internal medicine

Education History

Johns Hopkins University

United States

PHD :: Human Genetics Program

Publications

Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood cancer journal 14 (1) (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood cancer journal 14 (1) (2024)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia. Blood cancer journal 14 (1) (2024)
Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Xavier Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood advances (2024)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood cancer journal 14 (1) (2024)
Yi-Tsung Yang, Chi-Yuan Yao, Chein-Jun Kao, Po-Ju Chiu, Ming-En Lin, Hsin-An Hou, Chien-Chin Lin, Wen-Chien Chou, Hwei-Fang Tien
Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy. British journal of haematology (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia. Blood cancer journal 14 (1) (2024)
Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Xavier Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood advances 8 (10) (2024)
Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Xavier Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood advances 8 (10) (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
Chi-Yuan Yao, Chien-Chin Lin, Yu-Hung Wang, Chein-Jun Kao, Xavier Cheng-Hong Tsai, Hsin-An Hou, Hwei-Fang Tien, Chia-Lang Hsu, Wen-Chien Chou
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood advances 8 (10) (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia. Blood cancer journal 14 (1) (2024)
Britta Höchsmann, Regis Peffault de Latour, Anita Hill, Alexander Röth, Timothy Devos, Christopher Jordan Patriquin, Wen-Chien Chou, Deepak Jain, Ke Zu, Chuntao Wu, Jong Wook Lee
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry. Annals of hematology (2023)
Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood cancer journal 13 (1) (2023)
Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood cancer journal 13 (1) (2023)
Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood cancer journal 13 (1) (2023)
Wan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Yi-Tsung Yang, Jui-Che Chen, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Liang-In Lin, Wen-Chien Chou, Chien-Chin Lin, Hsin-An Hou, Hwei-Fang Tien
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification. Blood cancer journal 13 (1) (2023)
Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood cancer journal 13 (1) (2023)
Yu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, Kristian Gurashi, Fabio M R Amaral, Hasse Bossenbroek, Andrés Jerez, Tim C P Somervaille, Moritz Binder, Mrinal M Patnaik, Hsin-An Hou, Wen-Chien Chou, Kiran Batta, Daniel H Wiseman, Hwei-Fang Tien
A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia. British journal of haematology (2023)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Bettina Wingelhofer, Fabio M R Amaral, Chi-Yuan Yao, Hsin Ting Hsieh, Ming Chih Liu, Hsin-An Hou, Wen-Chien Chou, Kiran Batta, Daniel H Wiseman, Hwei-Fang Tien
Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target. Leukemia (2023)
Yu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, Chi-Ling Chen, Chia-Lang Hsu, Xavier Cheng-Hong Tsai, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Higher RUNX1 expression levels are associated with worse overall and leukaemia-free survival in myelodysplastic syndrome patients. EJHaem 3 (4) (2022)
Alexander E Perl, Naoko Hosono, Pau Montesinos, Nikolai A Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Recher, Catherine C Smith, Mark J Levis, Stephen A Strickland, Christoph Röllig, Marco Groß-Langenhoff, Wen-Chien Chou, Je Hwan Lee, Hisayuki Yokoyama, Nahla Hasabou, Qiaoyang Lu, Ramon V Tiu, Jessica K Altman
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib. Blood cancer journal 12 (5) (2022)
Tsung-Chih Chen, Chi-Yuan Yao, Yu-Ren Chen, Chang-Tsu Yuan, Chien-Chin Lin, Yueh-Chwen Hsu, Po-Han Chuang, Chein-Jun Kao, Yi-Hung Li, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair. Oncogene 41 (11) (2022)
Yu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, Chia-Lang Hsu, Xavier Cheng-Hong Tsai, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome. British journal of haematology (2021)
Feng-Ming Tien, Xavier Cheng-Hong Tsai, Sheng-Chuan Huang, Jia-Hau Liu, Chien-Yuan Chen, Yuan-Yeh Kuo, Yi-Kuang Chuang, Mei-Hsuan Tseng, Yen-Ling Peng, Ming-Chih Liu, Chia-Wen Liu, Xiu-Wen Liao, Liang-In Lin, Yu-Sin Wu, Mei-Fang Hou, Shang-Ju Wu, Szu-Chun Hsu, Bor-Sheng Ko, Wen-Chien Chou, Ming Yao, Hsin-An Hou, Jih-Luh Tang, Hwei-Fang Tien
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission. Bone marrow transplantation (2021)
Xavier Cheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, Yuan-Yeh Kuo, Dung-Chi Wu, Chien-Chin Lin, Mei-Hsuan Tseng, Yen-Ling Peng, Mei-Fang Hou, Yi-Kuang Chuang, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, Wen-Chien Chou, Chien-Yu Chen, Hsin-An Hou, Hwei-Fang Tien
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML. Blood advances 5 (10) (2021)
Chien-Chin Lin, Chi-Yuan Yao, Yueh-Chwen Hsu, Hsin-An Hou, Chang-Tsu Yuan, Yi-Hung Li, Chein-Jun Kao, Po-Han Chuang, Yu-Chiao Chiu, Yidong Chen, Wen-Chien Chou, Hwei-Fang Tien
Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice. Oncogene 39 (28) (2020)
Yu-Hung Wang, Chien-Chin Lin, Sze-Hwei Lee, Xavier Cheng-Hong Tsai, Shan-Ju Wu, Hsin-An Hou, Tai-Chung Huang, Yuan-Yeh Kuo, Ming Yao, Koping Chang, Chung-Wu Lin, Yun-Chu Lin, Feng-Ming Tien, Wen-Chien Chou, Jih-Luh Tang, Hwei-Fang Tien
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden. Blood cancer journal 10 (10) (2020)

Wen-Chien Chou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wen-Chien Chou